Sign In
Buy DGX
$193.67
+0.510 (+0.264%)
At Close: Jun 03, 2026
Quest Diagnostics Inc (NYSE:DGX) Shares Purchased by CIBC Asset Management Inc
10:48am, Saturday, 01'st Aug 2020
CIBC Asset Management Inc boosted its position in shares of Quest Diagnostics Inc (NYSE:DGX) by 2.6% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission.
Craving Healthcare: A Beginner's Guide And My 7 Picks
04:00pm, Friday, 31'st Jul 2020
The Healthcare sector has significantly outperformed the S&P 500 in the last decade and with lower volatility – the only sector to do so.
Craving Healthcare: A Beginner's Guide And My 7 Picks
12:00pm, Friday, 31'st Jul 2020
The Healthcare sector has significantly outperformed the S&P500 in the last decade and with lower volatility – the only sector to do so.
Quest Gets FDA Nod For Faster Covid-19 Testing; Analyst Flips To Buy Call
07:58am, Thursday, 30'th Jul 2020
Quest Diagnostics Inc. (DGX) announced that the U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for a new laboratory technique that speeds up COVID-19 molecular
Quest Gets FDA Emergency Approval For New Lab Method To Improve Coronavirus Testing Capacity, Speed
02:07am, Thursday, 30'th Jul 2020
Quest Diagnostics Inc (NYSE: DGX) announced Wednesday it had received an emergency use authorization from the Food and Drug Administration for a new laboratory technique that can help signficantly exp
Introducing The Pale Blue Portfolio
09:20pm, Wednesday, 29'th Jul 2020
The Pale Blue Portfolio prioritizes corporate responsibility and growth at a reasonable price. It limits the investing universe to companies that receive at least an A grade from MSCI's ESG database.
Quest gets FDA OK for speedier COVID-19 testing method
09:19pm, Wednesday, 29'th Jul 2020
Quest Diagnostics Inc. said late Wednesday that the U.S. Food and Drug Administration has granted an emergency-use authorization to its new laboratory technique to speed up COVID-19 testing. The new
Quest says FDA cleared new 'lab method' that will cut coronavirus testing delays
09:14pm, Wednesday, 29'th Jul 2020
"Covid-19 with the flu season is going to be more problematic than where we're at today," LabCorp CEO Adam Schechter said Tuesday.
FDA Authorizes New Quest Diagnostics Lab Method Designed to Increase COVID-19 Molecular Diagnostics Capacity
08:10pm, Wednesday, 29'th Jul 2020
Quest Diagnostics (NYSE:DGX) today announced that the U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for a new laboratory technique that speeds the process of ex
Introducing The Pale Blue Portfolio
05:20pm, Wednesday, 29'th Jul 2020
The Pale Blue Portfolio prioritizes corporate responsibility and growth at a reasonable price. It limits the investing universe to companies that receive at least an A grade from MSCI's ESG database.
KeyBanc Upgrades Quest Diagnostics, Says Lab Company's Guidance 'Very Cautious'
03:51pm, Wednesday, 29'th Jul 2020
Quest Diagnostics Inc (NYSE: DGX) is generating estimated earnings of around $1 per share from COVID-19 lab tests and the Public Health Emergency declaration could continue well into 2021, according t
Benzinga's Top Upgrades, Downgrades For July 29, 2020
01:38pm, Wednesday, 29'th Jul 2020
Upgrades * For Safe Bulkers Inc (NYSE: SB), DNB Markets upgraded the previous rating of Hold to the current rating Buy. For the first quarter, Safe Bulkers had an EPS of ($0.13), compared to year-ag
Here are Wednesday's biggest analyst calls of the day: Tesla, Apple, L Brands, Netflix & more
11:38am, Wednesday, 29'th Jul 2020
Here are the biggest calls on Wall Street on Wednesday
KeyBanc Upgrades Quest Diagnostics, Says Lab Company's Guidance 'Very Cautious'
12:00am, Wednesday, 29'th Jul 2020
Quest Diagnostics Inc (NYSE: DGX) is generating estimated earnings of around $1 per share from COVID-19 lab tests and the Public Health Emergency declaration could continue well...
Bill Gates says delays in coronavirus test results make them a 'complete waste,' 'insane'
01:01pm, Tuesday, 28'th Jul 2020
"You should not reimburse somebody for getting a test that it takes more than 48 hours to get the result back," Bill Gates told CNBC.
